Literature DB >> 31697811

Clonal hematopoiesis in elderly twins: concordance, discordance, and mortality.

Jakob Werner Hansen1,2,3, Dorthe Almind Pedersen4,5, Lisbeth Aagaard Larsen4,5, Simon Husby1,2,3, Signe Bedsted Clemmensen4,5, Jacob Hjelmborg4,5, Francesco Favero2,6, Joachim Weischenfeldt2,6, Kaare Christensen4,5, Kirsten Grønbæk1,2,3.   

Abstract

Clonal hematopoiesis (CH) of indeterminate potential (CHIP) is defined by mutations in myeloid cancer-associated genes with a variant allele frequency of at least 2%. Recent studies have suggested a possible genetic predisposition to CH. To further explore this phenomenon, we conducted a population-based study of 594 twins from 299 pairs aged 73 to 94 years, all with >20 years' follow-up. We sequenced DNA from peripheral blood with a customized 21-gene panel at a median coverage of 6179X. The casewise concordance rates for mutations were calculated to assess genetic predisposition. Mutations were identified in 214 (36%) of the twins. Whereas 20 twin pairs had mutations within the same genes, the exact same mutation was only observed in 2 twin pairs. No significant difference in casewise concordance between monozygotic and dizygotic twins was found for any specific gene, subgroup, or CHIP mutations overall, and no significant heritability could be detected. In pairs discordant for CHIP mutations, we tested if the affected twin died before the unaffected twin, as a direct measurement of the association of having CH when controlling for familial factors. A total of 127 twin pairs were discordant for carrying a mutation, and in 61 (48%) cases, the affected twin died first (P = .72). Overall, we did not find a genetic predisposition to CHIP mutations in this twin study. The previously described negative association of CHIP mutations on survival could not be confirmed in a direct comparison among twin pairs that were discordant for CHIP mutations.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2020        PMID: 31697811      PMCID: PMC6978157          DOI: 10.1182/blood.2019001793

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   25.476


  33 in total

1.  Uncompromised 10-year survival of oldest old carrying somatic mutations in DNMT3A and TET2.

Authors:  Erik B van den Akker; Steven J Pitts; Joris Deelen; Matthijs H Moed; Shobha Potluri; Jeroen van Rooij; H Eka D Suchiman; Nico Lakenberg; Wesley J de Dijcker; André G Uitterlinden; Robert Kraaij; Albert Hofman; Anton J M de Craen; Jeanine J Houwing-Duistermaat; Gert-Jan B van Ommen; David R Cox; Joyce B J van Meurs; Marian Beekman; Marcel J T Reinders; P Eline Slagboom
Journal:  Blood       Date:  2016-01-29       Impact factor: 22.113

2.  Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study.

Authors:  Anne C M Thiébaut; Jacques Bénichou
Journal:  Stat Med       Date:  2004-12-30       Impact factor: 2.373

3.  Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly.

Authors:  Florian Zink; Simon N Stacey; Gudmundur L Norddahl; Michael L Frigge; Olafur T Magnusson; Ingileif Jonsdottir; Thorgeir E Thorgeirsson; Asgeir Sigurdsson; Sigurjon A Gudjonsson; Julius Gudmundsson; Jon G Jonasson; Laufey Tryggvadottir; Thorvaldur Jonsson; Agnar Helgason; Arnaldur Gylfason; Patrick Sulem; Thorunn Rafnar; Unnur Thorsteinsdottir; Daniel F Gudbjartsson; Gisli Masson; Augustine Kong; Kari Stefansson
Journal:  Blood       Date:  2017-05-08       Impact factor: 22.113

4.  Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.

Authors:  Maya Lewinsohn; Anna L Brown; Luke M Weinel; Connie Phung; George Rafidi; Ming K Lee; Andreas W Schreiber; Jinghua Feng; Milena Babic; Chan-Eng Chong; Young Lee; Agnes Yong; Graeme K Suthers; Nicola Poplawski; Meryl Altree; Kerry Phillips; Louise Jaensch; Miriam Fine; Richard J D'Andrea; Ian D Lewis; Bruno C Medeiros; Daniel A Pollyea; Mary-Claire King; Tom Walsh; Siobán Keel; Akiko Shimamura; Lucy A Godley; Christopher N Hahn; Jane E Churpek; Hamish S Scott
Journal:  Blood       Date:  2015-12-28       Impact factor: 22.113

5.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.

Authors:  Giulio Genovese; Anna K Kähler; Robert E Handsaker; Johan Lindberg; Samuel A Rose; Samuel F Bakhoum; Kimberly Chambert; Eran Mick; Benjamin M Neale; Menachem Fromer; Shaun M Purcell; Oscar Svantesson; Mikael Landén; Martin Höglund; Sören Lehmann; Stacey B Gabriel; Jennifer L Moran; Eric S Lander; Patrick F Sullivan; Pamela Sklar; Henrik Grönberg; Christina M Hultman; Steven A McCarroll
Journal:  N Engl J Med       Date:  2014-11-26       Impact factor: 91.245

6.  Persistence of DNMT3A mutations at long-term remission in adult patients with AML.

Authors:  Gro G Pløen; Line Nederby; Per Guldberg; Maria Hansen; Lene H Ebbesen; Uffe Birk Jensen; Peter Hokland; Anni Aggerholm
Journal:  Br J Haematol       Date:  2014-08-04       Impact factor: 6.998

7.  Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia.

Authors:  Jane E Churpek; Khateriaa Pyrtel; Krishna-Latha Kanchi; Jin Shao; Daniel Koboldt; Christopher A Miller; Dong Shen; Robert Fulton; Michelle O'Laughlin; Catrina Fronick; Iskra Pusic; Geoffrey L Uy; Evan M Braunstein; Mark Levis; Julie Ross; Kevin Elliott; Sharon Heath; Allan Jiang; Peter Westervelt; John F DiPersio; Daniel C Link; Matthew J Walter; John Welch; Richard Wilson; Timothy J Ley; Lucy A Godley; Timothy A Graubert
Journal:  Blood       Date:  2015-10-22       Impact factor: 22.113

8.  Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms.

Authors:  Chantana Polprasert; Isabell Schulze; Mikkael A Sekeres; Hideki Makishima; Bartlomiej Przychodzen; Naoko Hosono; Jarnail Singh; Richard A Padgett; Xiaorong Gu; James G Phillips; Michael Clemente; Yvonne Parker; Daniel Lindner; Brittney Dienes; Eckhard Jankowsky; Yogen Saunthararajah; Yang Du; Kevin Oakley; Nhu Nguyen; Sudipto Mukherjee; Caroline Pabst; Lucy A Godley; Jane E Churpek; Daniel A Pollyea; Utz Krug; Wolfgang E Berdel; Hans-Ulrich Klein; Martin Dugas; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Kenichi Yoshida; Seishi Ogawa; Carsten Müller-Tidow; Jaroslaw P Maciejewski
Journal:  Cancer Cell       Date:  2015-04-23       Impact factor: 31.743

9.  Age-related mutations associated with clonal hematopoietic expansion and malignancies.

Authors:  Mingchao Xie; Charles Lu; Jiayin Wang; Michael D McLellan; Kimberly J Johnson; Michael C Wendl; Joshua F McMichael; Heather K Schmidt; Venkata Yellapantula; Christopher A Miller; Bradley A Ozenberger; John S Welch; Daniel C Link; Matthew J Walter; Elaine R Mardis; John F Dipersio; Feng Chen; Richard K Wilson; Timothy J Ley; Li Ding
Journal:  Nat Med       Date:  2014-10-19       Impact factor: 53.440

10.  Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia.

Authors:  Liran I Shlush; Sasan Zandi; Amanda Mitchell; Weihsu Claire Chen; Joseph M Brandwein; Vikas Gupta; James A Kennedy; Aaron D Schimmer; Andre C Schuh; Karen W Yee; Jessica L McLeod; Monica Doedens; Jessie J F Medeiros; Rene Marke; Hyeoung Joon Kim; Kwon Lee; John D McPherson; Thomas J Hudson; Andrew M K Brown; Fouad Yousif; Quang M Trinh; Lincoln D Stein; Mark D Minden; Jean C Y Wang; John E Dick
Journal:  Nature       Date:  2014-02-12       Impact factor: 69.504

View more
  18 in total

1.  High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential.

Authors:  Lambert Busque; Maxine Sun; Manuel Buscarlet; Sami Ayachi; Yassamin Feroz Zada; Sylvie Provost; Vincent Bourgoin; Luigina Mollica; Marlies Meisel; Reinhard Hinterleitner; Bana Jabri; Marie-Pierre Dubé; Jean-Claude Tardif
Journal:  Blood Adv       Date:  2020-06-09

2.  [Clonal hematopoiesis: causes and clinical implications].

Authors:  Andreas Burchert
Journal:  Inn Med (Heidelb)       Date:  2022-08-15

Review 3.  Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-09-01       Impact factor: 3.122

Review 4.  Inflammation in Myeloid Malignancies: From Bench to Bedside.

Authors:  Eli M Soyfer; Angela G Fleischman
Journal:  J Immunother Precis Oncol       Date:  2021-07-14

5.  In utero origin of myelofibrosis presenting in adult monozygotic twins.

Authors:  Nikolaos Sousos; Máire Ní Leathlobhair; Christina Simoglou Karali; Eleni Louka; Nicola Bienz; Daniel Royston; Sally-Ann Clark; Angela Hamblin; Kieran Howard; Vikram Mathews; Biju George; Anindita Roy; Bethan Psaila; David C Wedge; Adam J Mead
Journal:  Nat Med       Date:  2022-05-30       Impact factor: 87.241

Review 6.  Germline risk of clonal haematopoiesis.

Authors:  Alexander J Silver; Alexander G Bick; Michael R Savona
Journal:  Nat Rev Genet       Date:  2021-05-13       Impact factor: 53.242

Review 7.  Myelodysplastic syndromes: moving towards personalized management.

Authors:  Eva Hellström-Lindberg; Magnus Tobiasson; Peter Greenberg
Journal:  Haematologica       Date:  2020-05-21       Impact factor: 9.941

8.  Stem cell donors should be screened for CHIP.

Authors:  Amy E DeZern; Lukasz P Gondek
Journal:  Blood Adv       Date:  2020-02-25

Review 9.  Fate of Hematopoiesis During Aging. What Do We Really Know, and What are its Implications?

Authors:  Hal E Broxmeyer; Yan Liu; Reuben Kapur; Christie M Orschell; Arafat Aljoufi; James P Ropa; Thao Trinh; Sarah Burns; Maegan L Capitano
Journal:  Stem Cell Rev Rep       Date:  2020-11-03       Impact factor: 5.739

Review 10.  Cytokine Profiling in Myeloproliferative Neoplasms: Overview on Phenotype Correlation, Outcome Prediction, and Role of Genetic Variants.

Authors:  Elena Masselli; Giulia Pozzi; Giuliana Gobbi; Stefania Merighi; Stefania Gessi; Marco Vitale; Cecilia Carubbi
Journal:  Cells       Date:  2020-09-21       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.